Feczkó T - Search Results

1

Topical Formulation of Nano Spray-Dried Levocetirizine Dihydrochloride against Allergic Edema.

Mirankó M, Tóth J, Fodor-Kardos A, Móricz K, Szenes-Nagy AB, Gácsi A, Spaits T, Gyenis J, Feczkó T. Mirankó M, et al. Among authors: feczko t. Pharmaceutics. 2022 Nov 23;14(12):2577. doi: 10.3390/pharmaceutics14122577. Pharmaceutics. 2022. PMID: 36559070 Free PMC article.

2

Preparation of chitosan particles suitable for enzyme immobilization.

Biró E, Németh AS, Sisak C, Feczkó T, Gyenis J. Biró E, et al. Among authors: feczko t. J Biochem Biophys Methods. 2008 Apr 24;70(6):1240-6. doi: 10.1016/j.jprot.2007.11.005. Epub 2007 Nov 19. J Biochem Biophys Methods. 2008. PMID: 18155771

3

Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: part I. Effect of process variables on the mean size.

Shubhra QT, Kardos AF, Feczkó T, Mackova H, Horák D, Tóth J, Dósa G, Gyenis J. Shubhra QT, et al. Among authors: feczko t. J Microencapsul. 2014;31(2):147-55. doi: 10.3109/02652048.2013.814729. Epub 2013 Jul 22. J Microencapsul. 2014. PMID: 23875616

4

Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: part II. Effect of process variables on protein model drug encapsulation efficiency.

Shubhra QT, Feczkó T, Kardos AF, Tóth J, Mackova H, Horak D, Dósa G, Gyenis J. Shubhra QT, et al. Among authors: feczko t. J Microencapsul. 2014;31(2):156-65. doi: 10.3109/02652048.2013.814730. Epub 2013 Jul 22. J Microencapsul. 2014. PMID: 23875617

5

Surface modification of HSA containing magnetic PLGA nanoparticles by poloxamer to decrease plasma protein adsorption.

Shubhra QTH, Tóth J, Gyenis J, Feczkó T. Shubhra QTH, et al. Among authors: feczko t. Colloids Surf B Biointerfaces. 2014 Oct 1;122:529-536. doi: 10.1016/j.colsurfb.2014.07.025. Epub 2014 Jul 22. Colloids Surf B Biointerfaces. 2014. PMID: 25092588

6

In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.

Feczkó T, Fodor-Kardos A, Sivakumaran M, Haque Shubhra QT. Feczkó T, et al. Nanomedicine (Lond). 2016 Aug;11(16):2029-34. doi: 10.2217/nnm-2016-0058. Epub 2016 Jul 27. Nanomedicine (Lond). 2016. PMID: 27462975

7

Preparation of cubic-shaped sorafenib-loaded nanocomposite using well-defined poly(vinyl alcohol alt-propenylene) copolymer.

Feczkó T, Merza G, Babos G, Varga B, Gyetvai E, Trif L, Kovács E, Tuba R. Feczkó T, et al. Int J Pharm. 2019 May 1;562:333-341. doi: 10.1016/j.ijpharm.2019.03.008. Epub 2019 Mar 10. Int J Pharm. 2019. PMID: 30867128

8

Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques.

Feczkó T, Piiper A, Pleli T, Schmithals C, Denk D, Hehlgans S, Rödel F, Vogl TJ, Wacker MG. Feczkó T, et al. Pharmaceutics. 2019 Sep 23;11(10):489. doi: 10.3390/pharmaceutics11100489. Pharmaceutics. 2019. PMID: 31548500 Free PMC article.

9

Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery.

Babos G, Rydz J, Kawalec M, Klim M, Fodor-Kardos A, Trif L, Feczkó T. Babos G, et al. Among authors: feczko t. Int J Mol Sci. 2020 Oct 3;21(19):7312. doi: 10.3390/ijms21197312. Int J Mol Sci. 2020. PMID: 33022990 Free PMC article.

10

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit^® RLPO.

Hajba-Horváth E, Fodor-Kardos A, Shah N, Wacker MG, Feczkó T. Hajba-Horváth E, et al. Among authors: feczko t. Int J Mol Sci. 2021 Dec 2;22(23):13069. doi: 10.3390/ijms222313069. Int J Mol Sci. 2021. PMID: 34884873 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters